Elsevier

Current Opinion in Biotechnology

Volume 48, December 2017, Pages 85-93
Current Opinion in Biotechnology

Applying the design-build-test paradigm in microbiome engineering

https://doi.org/10.1016/j.copbio.2017.03.021Get rights and content

Highlights

  • Recent progress in microbiome engineering is reviewed.

  • Design principles to engineer the human microbiome are reviewed.

  • Methods to engineer microbiome with desired functions are reviewed.

  • The ‘design-build-test’ cycle can expedite microbiome engineering.

The recently discovered roles of human microbiome in health and diseases have inspired research efforts across many disciplines to engineer microbiome for health benefits. In this review, we highlight recent progress in human microbiome research and how modifications to the microbiome could result in implications to human health. Furthermore, we discuss the application of a ‘design-build-test’ framework to expedite microbiome engineering efforts by reviewing current literature on three key aspects: design principles to engineer the human microbiome, methods to engineer microbiome with desired functions, and analytical techniques to examine complex microbiome samples.

Introduction

Recent discoveries on the roles of the human gut microbiome in health and diseases have inspired novel means for prophylactic and therapeutic intervention against disease onset and progression. The engineering of human microbiome for health benefits and related applications could be observed across many disciplines in nanotechnology, chemistry, and biology. Nanoscale instruments are being fabricated to interface with human microbiome for real-time monitoring of health status, or for on-site protection against early disease onset [1]. Chemical microbiome modifiers, such as prebiotics, probiotics, and antibiotics, have long been prescribed by doctors for disease treatment [2]. With the advent of DNA sequencing and metabolomics tools allowing data analysis at higher resolution and throughput, interests to develop biological modifiers for in situ precision engineering of the human microbiome are increasingly gaining momentum [3, 4••, 5]. Synthetic biology envisages microbiome engineering as one of the grand frontiers of precision medicine. Genetic programs have been installed into single-species microbial communities to perform diagnostic and therapeutic operations, such as regulating glucose level in the blood, or detecting liver metastasis in urine [6, 7]. Alongside these developments, there is emerging global interest to expand the said conceptual frameworks for the development of synthetic cellular consortia that could enable targeted engineering of the human microbiome and deliver the corresponding health benefits [5]. The ‘design-build-test’ (DBT) cycle is an engineering paradigm that is widely practiced among engineering disciplines for the design of experiments and the rational optimization of technology. In this review, we aim to demonstrate how the DBT cycle can be strategically applied to expedite microbiome engineering efforts. To support this proposition, we herein assess the status of human gut microbiome engineering with a focus on three key aspects: design principles to engineer the human microbiome, methods to reassemble microbiome with desired functions, and analytical techniques to examine complex microbiome samples.

Section snippets

Design

Harnessing the design principles of natural microbiome represents a pioneering step for rational microbiome engineering. In this section, we review the current knowledge on fundamental design features of natural human gut microbiome, including the composition and dynamics, biogeography, and metabolic activity (Figure 1). Examples illustrating the application of these understanding to modify microbiome are presented.

Build

Current microbiome engineering methods aim to introduce specific perturbation to cause the intentional shift and transition of the human microbiota. Subsequently, the composition and metagenome of the re-assembled microbiota could be correlated with host physiology changes to identify and augment microbial functions that contribute to specific health conditions [4••]. Ongoing efforts to engineer the microbiome can be classified as either abiotic perturbation, including drug treatment and

Test

Possessing the capability to analyze complex microbial samples in high-throughput workflows is critical in advancing current knowledge and application in microbiome engineering. In this section, we survey the status of contemporary tools for microbiome testing and analysis, particularly on cutting-edge tools for transcriptomics, metagenomics, proteomics, and metabolomics (Figure 3).

Conclusion

In this review, we describe various aspects of the human microbiome and how modifications to the composition and functionality of the microbiome can result in implications to human health. Understanding these fundamental mechanisms allow us to formulate design principles and strategies to enable rational engineering and analysis of the human microbiome at multi-species community levels. Despite the rapid advancement of human microbiome knowledge, it is critical to acknowledge that the

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest

  • •• of outstanding interest

Acknowledgements

This work was supported by the Synthetic Biology Initiative of the National University of Singapore (DPRT/943/09/14), the Summit Research Program of the National University Health System (NUHSRO/2016/053/SRP/05), the Ministry of Defence of Singapore (MINDEF, RE2016-074), the Singapore Ministry of Education (MOE/2014/T2/2/128), the US Air Force (AOARD, FA2386-14-1-4060) and the U.S. Defense Threat Reduction Agency (DTRA, HDTRA1-13-0037).

References (73)

  • N. Saeidi et al.

    Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen

    Mol. Syst. Biol.

    (2011)
  • F. Duan et al.

    Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model

    Proc. Natl. Acad. Sci. U. S. A.

    (2010)
  • Z. Chen et al.

    Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity

    J. Clin. Invest.

    (2014)
  • J.S. Biteen et al.

    Tools for the microbiome: nano and beyond

    ACS Nano

    (2016)
  • B. Hamad

    The antibiotics market

    Nat. Rev. Drug Discov.

    (2010)
  • K. Garber

    Drugging the gut microbiome

    Nat. Biotechnol.

    (2015)
  • M. Mimee et al.

    Microbiome therapeutics—advances and challenges

    Adv. Drug Deliv. Rev.

    (2016)
  • T. Danino et al.

    Programmable probiotics for detection of cancer in urine

    Sci. Transl. Med.

    (2015)
  • M.G. Dominguez-Bello et al.

    Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

    Proc. Natl. Acad. Sci. U. S. A.

    (2010)
  • I. Cho et al.

    Antibiotics in early life alter the murine colonic microbiome and adiposity

    Nature

    (2012)
  • A. Bergstrom et al.

    Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants

    Appl. Environ. Microbiol.

    (2014)
  • The Human Microbiome Project Consortium

    Structure, function and diversity of the healthy human microbiome

    Nature

    (2012)
  • J.J. Faith et al.

    The long-term stability of the human gut microbiota

    Science

    (2013)
  • P.J. Turnbaugh et al.

    An obesity-associated gut microbiome with increased capacity for energy harvest

    Nature

    (2006)
  • M.C. Arrieta et al.

    Early infancy microbial and metabolic alterations affect risk of childhood asthma

    Sci. Transl. Med.

    (2015)
  • A.T. Stefka et al.

    Commensal bacteria protect against food allergen sensitization

    Proc. Natl. Acad. Sci. U. S. A.

    (2014)
  • N.F. Villarino et al.

    Composition of the gut microbiota modulates the severity of malaria

    Proc. Natl. Acad. Sci. U. S. A.

    (2016)
  • H.K. Pedersen et al.

    Human gut microbes impact host serum metabolome and insulin sensitivity

    Nature

    (2016)
  • W.S. Garrett

    Cancer and the microbiota

    Science

    (2015)
  • E. Biagi et al.

    Gut microbiota and extreme longevity

    Curr. Biol.

    (2016)
  • N.R. Salama et al.

    Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori

    Nat. Rev. Microbiol.

    (2013)
  • M. Amieva et al.

    Pathobiology of Helicobacter pylori-induced gastric cancer

    Gastroenterol

    (2016)
  • M. Mimee et al.

    Programming a human commensal bacterium Bacteroides thetaiotaomicron, to sense and respond to stimuli in the murine gut microbiota

    Cell Syst.

    (2016)
  • J.M. Yano et al.

    Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis

    Cell

    (2015)
  • D. Erny et al.

    Host microbiota constantly control maturation and function of microglia in the CNS

    Nat. Neurosci.

    (2015)
  • C.G. Buffie et al.

    Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

    Nature

    (2015)
  • Cited by (12)

    • Time to integrate biotechnological approaches into fish gut microbiome research

      2022, Current Opinion in Biotechnology
      Citation Excerpt :

      Although currently none of these tools involve microbial communities, these tools could be of great value for future microbiome research. To further understand the impact of microbiome modulation, current microbiome engineering methods can be used to introduce a specific perturbation to cause intentional shifts in human studies [46]. Such perturbations can be either biotic (microbial transplants, probiotics, phages) or abiotic (dietary changes, antibiotics/xenobiotics use).

    • Predictive interactome modeling for precision microbiome engineering

      2020, Current Opinion in Chemical Engineering
      Citation Excerpt :

      Microbiome engineering for controllable outcomes requires computational models that enable integrating the high dimensionality of microbiome data to propose optimal intervention or design strategies [15,16]. Rational microbiome engineering can be framed to follow a design-build-test-learning cycle [17••,18], among which the ‘design’ step is a critical part that can greatly benefit from predictive mathematical modeling and data integration. The utility of computational models in microbiome design, particularly those enabling accurately predicting microbial interactions, has been highlighted through a recently proposed workflow, termed Biological Computer-Aided Design of Interactions (BioCADi) [19].

    • A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing

      2020, Biosensors and Bioelectronics
      Citation Excerpt :

      In particular, probiotics have been actively serving as a chassis and have been reprogrammed through genetic circuits to sense disease biomarkers and to deliver therapeutics efficiently with site specificity (Singh et al., 2017). Similar to commensal bacteria in the gut, these designer probiotics can also sense, respond to, and control the gut environment (Hwang and Chang, 2020; Pham et al., 2017). The mammalian gut is home to a diverse community of commensal, symbiotic, and even pathogenic microbes (Mimee et al., 2016) and plays active roles in human health, including metabolism (Fischbach and Sonnenburg, 2011), immunity (Belkaid and Hand, 2014), and the gut-brain axis (Sampson and Mazmanian, 2015).

    View all citing articles on Scopus
    *

    These authors contributed equally to this work.

    View full text